Search - tctmd.com

Displaying 161 - 180 of 393

Sort: Relevancy | Date

Presentation TCT 2017

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

Presenter: Dariusz Dudek, Martin Hudec, Michael Haude

October 30, 2017

Presentation TCT 2017

Research Opportunities in PE Therapy

Presenter: Michael R. Jaff, Robert A. Lookstein

October 30, 2017

Presentation TCT 2017

Techniques and Outcomes of PE Lysis: Is Catheter-Directed Thrombolysis Really Better Than IV Lytics?

Presenter: Michael R. Jaff, Robert A. Lookstein, Jay S. Giri

October 30, 2017

Presentation TCT 2017

Is PE Really a Team Sport? Benefits and Disadvantages of PERT

Presenter: Michael R. Jaff, Robert A. Lookstein, Kenneth Rosenfield

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients?

Presenter: C. Michael Gibson, Stephan Windecker

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

Presenter: C. Michael Gibson, Stephan Windecker, Stephan Achenbach

October 30, 2017

Presentation TCT 2017

Optimal Techniques for Catheter-Directed Thrombolysis

Presenter: Michael R. Jaff, Robert A. Lookstein

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy?

Presenter: C. Michael Gibson, Stephan Windecker, Eric R. Bates

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI?

Presenter: C. Michael Gibson, Stephan Windecker, David Hildick-Smith

October 30, 2017

Presentation TCT 2017

Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI

Presenter: Grzegorz L. Kaluza, Jose M. Wiley, Michael C. Kim

October 29, 2017

Presentation TCT 2017

Surgical Repair vs Replacement for Severe Secondary MR

Presenter: Jeroen J. Bax, Stephan Windecker, Michael A. Borger

October 29, 2017

Presentation TCT 2017

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Anthony H. Gershlick

October 29, 2017

Presentation TCT 2017

Debate: Revascularization of Left Main Disease - CABG Remains Standard of Care

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker

October 29, 2017

Presentation TCT 2017

Debate: Revascularization of Left Main Disease - PCI Should Be Preferred in EXCEL-Like Patients

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Adrian P. Banning

October 29, 2017

News Daily News

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

Michael O'Riordan

October 27, 2017

News Daily News

Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients

Michael O'Riordan

October 26, 2017

News Daily News

Statins and Diabetes: Causal Link Reinforced in New Analysis

Michael O'Riordan

October 25, 2017

News Daily News

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Michael O'Riordan

October 24, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

Advertisement

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

Research Opportunities in PE Therapy

Techniques and Outcomes of PE Lysis: Is Catheter-Directed Thrombolysis Really Better Than IV Lytics?

Is PE Really a Team Sport? Benefits and Disadvantages of PERT

Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients?

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

Optimal Techniques for Catheter-Directed Thrombolysis

Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy?

Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI?

Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI

Surgical Repair vs Replacement for Severe Secondary MR

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

Debate: Revascularization of Left Main Disease - CABG Remains Standard of Care

Debate: Revascularization of Left Main Disease - PCI Should Be Preferred in EXCEL-Like Patients

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients

Statins and Diabetes: Causal Link Reinforced in New Analysis

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content